This wiki has undergone a migration to Confluence found Here
2017-11-15 SGB Conference Call
Jump to navigation
Jump to search
back to Standards Governance Board main page
| HL7 SGB Minutes |
Date: 2017-11-15 Time: 10:00 AM Eastern | ||
| Facilitator | Paul/Calvin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| x | Lorraine Constable | ||
| x | Russ Hamm | ||
| Regrets | Tony Julian | ||
| x | Paul Knapp | ||
| x | Austin Kreisler | ||
| Wayne Kubick | |||
| Thom Kuhn | |||
| Ken McCaslin | |||
| Rik Smithies | |||
| Sandy Stuart | |||
| Quorum: Chair + 4 | |||
Agenda
- Agenda review
- Approve Minutes of 2017-11-08_SGB_Conference_Call
- Action Items
- Review GOM with respect to where SGB and precepts should be reflected
- Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
- Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
- Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
- Discussion Topics
- Finish review of mixed ballot content precept
- Precept implementation strategy
- Backwards compatibility consistency and definition across families
- Product families to develop an approach to indicating the maturity of the products
- Precepts to Develop
- Parking Lot
- Review Publishing M&C updates regarding dual roles
- How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
- Review Mission and Charter
- Handling situations where two documents come out of one project
- FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
- Drafting Shared Product Management Responsibilities
- Levels of standards
- Separation of concerns
- Ownership of content
- ISM
- Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize
Minutes
- Agenda review
- Discussion re: next week's call.
- Add finishing up Product Life Cycle document
- Approve Minutes of 2017-11-08_SGB_Conference_Call
- MOTION to approve: Calvin/Paul
- VOTE: All in favor
- Action Items
- Review GOM with respect to where SGB and precepts should be reflected
- ACTION: Move to parking lot
- Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
- ACTION: Remove from actions
- Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
- ACTION: Anne to email item to Paul
- Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
- Carry forward to next week
- Review GOM with respect to where SGB and precepts should be reflected
- Discussion Topics
- Review TSC recommendations on Product Life Cycle document.
- Narrowed groups affected to formalized product families. Will add more as they form. Edited the application of the precept section. Discussion over reviewing the BAM in light of this precept.
- ACTION: Anne to add to TSC agenda
- Narrowed groups affected to formalized product families. Will add more as they form. Edited the application of the precept section. Discussion over reviewing the BAM in light of this precept.
- Finish review of mixed ballot content precept
- Group reviews. Made minor edits.
- ACTION: Review further on 2017-11-29 call
- Group reviews. Made minor edits.
- Precept implementation strategy
- Backwards compatibility consistency and definition across families
- Product families to develop an approach to indicating the maturity of the products
- Remove
- Review TSC recommendations on Product Life Cycle document.
- Precepts to Develop
- Parking Lot
- Review Publishing M&C updates regarding dual roles
- How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
- Review Mission and Charter
- Handling situations where two documents come out of one project
- FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
- Drafting Shared Product Management Responsibilities
- Levels of standards
- Separation of concerns
- Ownership of content
- ISM
- Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved
